Authorities in South Korea have emphasized the continued importance of fostering the biopharma and other health-related sectors, after stepping up regulatory innovation in 2023 to help develop them into national flagship industries and to match standards of other major regulator agencies around the world.
Korea Review/Outlook: Biopharma Support Policies, Regulatory Innovation In The Spotlight
Long-Awaited 'Control Tower' Kicks Off
Steps to foster the biopharma industry, a regulatory science innovation law and a new pan-government policy control tower were among the highlights of policy and regulatory activity in South Korea in 2023 set to have an ongoing impact throughout this year.
